-
公开(公告)号:WO2022148203A1
公开(公告)日:2022-07-14
申请号:PCT/CN2021/136470
申请日:2021-12-08
申请人: 石家庄以岭药业股份有限公司
发明人: 贾振华
IPC分类号: A61K36/8966 , A61K36/8888 , A61K36/752 , A61K36/736 , A61K36/708 , A61K36/634 , A61K36/605 , A61K36/539 , A61K36/484 , A61K36/355 , A61K36/346 , A61K36/28 , A61K36/23 , A61K36/17 , A61K33/06 , A61P31/12 , A61P37/02
摘要: 一种中药组合物及其应用。所述中药组合物由原料药麻黄、石膏、连翘、黄芩、桑白皮、苦杏仁、前胡、半夏、陈皮、贝母、牛蒡子、金银花、大黄、桔梗、甘草制成。所述中药组合物具有抗病毒、保护脏器、提高免疫力的作用。
-
公开(公告)号:WO2022052017A1
公开(公告)日:2022-03-17
申请号:PCT/CN2020/114666
申请日:2020-09-11
申请人: LIU, Hsuan-Miao
IPC分类号: A61K31/216 , A61K31/235 , A61K31/352 , A61K31/7048 , A61K31/704 , A61K31/12 , A61K31/365 , A61K36/282 , A61K36/605 , A61K36/533 , A61K36/81 , A61K36/899 , A61K36/9066 , A61K36/484 , A61P21/00
摘要: Disclosed herein are pharmaceutical compositions and uses thereof in treating muscle atrophy. The pharmaceutical composition comprises an ethanol extract of an herbal mixture consisting of Artemisia argyi, Morus alba L., Leonurus japonicus Houtt, Capsicum annuum L., Lophatherum gracile Brongn, Curcuma longa, and Glycyrrhiza uralensis; and a pharmaceutically acceptable excipient. The ethanol extract comprise 14 ingredients, including chlorogenic acid, leonurine, schaftoside, rutin, isochaftoside, isochlorogenic acid, 4, 5-dicaffeoylquinic acid, quercetin, apigenin, glycyrrhizic acid, bisdemethoxycurcumin, demethoxycurcumin, curcumin and artemisetin.
-
公开(公告)号:WO2022039700A1
公开(公告)日:2022-02-24
申请号:PCT/TR2021/050798
申请日:2021-08-12
发明人: BASLIK, Hakan
IPC分类号: A61K36/81 , A61K36/605 , A61K36/57 , A61K36/185 , A61K36/60 , A61K36/63 , A61P37/02
摘要: The present invention relates to an immune-enhancer and anti-ageing homogeneous nutraceutical or pharmaceutical composition. Accordingly, said homogeneous nutraceutical or pharmaceutical composition contains completely herbal-based hot pepper, black mulberry, anise, stinging nettle, fig, olive, semen pegani, mistletoe and poppy components. In this way, it is possible to obtain anti-ageing fatty acids and phenolic compounds for the human body.
-
公开(公告)号:WO2021214326A1
公开(公告)日:2021-10-28
申请号:PCT/EP2021/060744
申请日:2021-04-23
发明人: DARIMONT-NICOLAU, Christian , EGLI, Léonie , GHELDOF, Nele , RYTZ, Andreas , SATHYAVAGEESWARAN, Shreeram
IPC分类号: A61K36/605 , A61P3/00 , A61P3/10
摘要: A method for reducing postprandial glucose from a balanced meal includes orally administering to an individual a composition containing mulberry extract together with the meal. The postprandial glucose is reduced relative to postprandial glucose from administering a corresponding composition comprising mulberry extract before subsequent administration of the balanced meal.
-
5.
公开(公告)号:WO2021053641A2
公开(公告)日:2021-03-25
申请号:PCT/IB2020/058777
申请日:2020-09-21
申请人: SOFAR S.P.A.
发明人: BIFFI, Andrea , FIORE, Walter
IPC分类号: A61K35/745 , A61K35/747 , A61K36/185 , A61K36/605 , A61K36/73 , A61P29/00 , A61K36/45
摘要: The present invention relates to compositions B comprising a mixture comprising or, alternatively, consisting of: at least one bacterial strain selected from a group comprising or, alternatively, consisting of bacterial strains belonging to the species Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium bifidum and Bifidobacterium animalis subsp. Lactis, and preferably, at least one extract of at least one species of berries comprising a polyphenol fraction of said berries. Furthermore, the present invention relates to said compositions B for use as immunomodulatory and anti-inflammatory agents.
-
公开(公告)号:WO2020058817A1
公开(公告)日:2020-03-26
申请号:PCT/IB2019/057764
申请日:2019-09-16
IPC分类号: A61K36/24 , A61K36/59 , A61K36/60 , A61K36/61 , A61K36/9066 , A61K36/18 , A61K36/81 , A61K36/53 , A61K36/54 , A61K36/8962 , A61K36/899 , A61K36/605 , A61K36/38 , A61K36/29 , A61K36/73 , A61K35/04 , A61K31/198 , A61K31/205 , A61K33/24 , A61K33/06 , A61K33/30 , A61P3/10
摘要: The present invention relates to a synergistic pharmaceutical composition comprising of therapeutically effective amount of plant extracts, therapeutically effective amount of amino acids, elemental chromium, elemental magnesium, elemental zinc and optionally one or more pharmaceutical excipient(s), and a process for its preparation thereof.
-
公开(公告)号:WO2019015103A1
公开(公告)日:2019-01-24
申请号:PCT/CN2017/103554
申请日:2017-09-27
申请人: 淄博齐鼎立专利信息咨询有限公司
发明人: 王淑英
IPC分类号: A61K36/889 , A61K36/8888 , A61K36/86 , A61K36/716 , A61K36/605 , A61K36/515 , A61K36/288 , A61K9/48 , A61K9/14 , A61K9/08 , A61P29/00 , A61P19/06
CPC分类号: A61K9/08 , A61K9/14 , A61K9/48 , A61K36/288 , A61K36/515 , A61K36/605 , A61K36/716 , A61K36/86 , A61K36/8888 , A61K36/889 , A61P19/02 , A61P19/06 , A61P29/00
摘要: 一种中药,原料药为:桑白皮15份、紫背天葵9份、大腹皮15份、紫花地丁12份、蒲公英15份、龙胆草6份、威灵仙15份、半夏10份。该中药能够治疗痛风性关节炎。
-
公开(公告)号:WO2019013172A1
公开(公告)日:2019-01-17
申请号:PCT/JP2018/025905
申请日:2018-07-09
申请人: 株式会社 きものブレイン
IPC分类号: A23L33/17 , A23L33/105 , A61K9/14 , A61K35/64 , A61K36/605 , A61K38/02 , A61K38/39 , A61K127/00 , A61P3/04 , A61P3/06 , A61P3/10
CPC分类号: A23L33/105 , A23L33/17 , A61K9/14 , A61K35/63 , A61K36/605 , A61K38/02 , A61K38/39 , A61P3/04 , A61P3/06 , A61P3/10
摘要: 養蚕農家や養蚕事業者などの養蚕を営むものが容易に入手可能な蚕由来成分(蚕の繭や桑の葉)を用い、糖尿病患者やその予備軍並びにメタボリック症候群対象者に対して有用な蚕繭由来成分含有健康食品を提供することを目的とする。蚕の繭から得られるフィブロイン、又は蚕の繭から得られるセリシンの少なくともいずれか一方と、桑の葉とを有効成分として含有する蚕繭由来成分含有健康食品。
-
公开(公告)号:WO2018226060A1
公开(公告)日:2018-12-13
申请号:PCT/KR2018/006508
申请日:2018-06-08
申请人: 계명대학교 산학협력단 , 경북대학교 산학협력단
IPC分类号: A61K31/352 , A61K36/605 , A23L33/10 , A23L33/105
CPC分类号: A23L33/10 , A23L33/105 , A61K31/352 , A61K36/605
摘要: 본 발명은 신장 보호 활성을 갖는 쿠드라트리쿠스잔톤 A(Cudratricusxanthone A)를 유효성분으로 포함하는 신장 질환 예방 또는 치료용 약학 조성물, 건강기능식품 조성물 또는 신장 보호용 건강기능식품 조성물에 관한 것으로, 상기 쿠드라트리쿠스잔톤 A는 신장 기능이 손상된 마우스 모델에서 신장의 독성을 감소시키고 산화적 스트레스로부터 신장을 보호하는 효과를 나타낸 바, 이를 유효성분으로 포함하는 조성물은 신장 질환 예방, 개선, 치료용 조성물 내지는 신장 보호용 건강기능식품 조성물로 유용하게 활용될 수 있다.
-
公开(公告)号:WO2018134738A1
公开(公告)日:2018-07-26
申请号:PCT/IB2018/050277
申请日:2018-01-17
申请人: SAFENAT S.R.L.
IPC分类号: A61K36/752 , A61K36/899 , A61K31/7032 , A61K31/7048 , A61K36/28 , A61K36/605 , A61K36/63 , A61K36/73 , A61P27/02 , A61P27/10 , A61K9/20 , A61K9/48
摘要: The present invention relates to nutraceutical or pharmaceutical compositions based on combination of cyanidin-3-O-glucoside and verbascoside, or extracts of plant origin enriched in the two active ingredients, with a protective action on eyesight.
-
-
-
-
-
-
-
-
-